Search research articles
Contact Us
Filters
Showing results (11-20 of 44) with videos related to
Page
of 5
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2013
A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor
P Ravi, K P Gray, E K O'Donnell, et al.
The Journal of Psychology
|
March 1, 1970
A test of the inverted-U hypothesis relating achievement anxiety and academic test performance
C J Sweeney, A D Smouse, O Rupiper, et al.
Lancet (London, England)
|
October 27, 1998
Thrombotic thrombocytopenic purpura and simvastatin
L J McCarthy, P Porcu, C A Fausel, et al.
The American Journal of Surgical Pathology
|
September 16, 1998
Nephroblastoma-like tumors in patients with testicular germ cell tumors
H Michael, M T Hull, R S Foster, et al.
International Journal of Oncology
|
July 13, 1999
Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression
M T Yip-Schneider, A Lin, D Barnard, et al.
The Journal of Urology
|
May 8, 2000
Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection
B P Hermans, C J Sweeney, R S Foster, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 16, 2001
Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells
M T Yip-Schneider, C J Sweeney, S H Jung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2010
Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer
J Flanagan, P Kathryn Gray, N Hahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer
C J Sweeney, B P Hermans, D K Heilman, et al.
Cancer Research
|
April 20, 2001
The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors
C J Sweeney, K D Miller, S E Sissons, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 44) with videos related to
Sort By:
Page
of 5
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2013
A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor
P Ravi, K P Gray, E K O'Donnell, et al.
The Journal of Psychology
|
March 1, 1970
A test of the inverted-U hypothesis relating achievement anxiety and academic test performance
C J Sweeney, A D Smouse, O Rupiper, et al.
Lancet (London, England)
|
October 27, 1998
Thrombotic thrombocytopenic purpura and simvastatin
L J McCarthy, P Porcu, C A Fausel, et al.
The American Journal of Surgical Pathology
|
September 16, 1998
Nephroblastoma-like tumors in patients with testicular germ cell tumors
H Michael, M T Hull, R S Foster, et al.
International Journal of Oncology
|
July 13, 1999
Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression
M T Yip-Schneider, A Lin, D Barnard, et al.
The Journal of Urology
|
May 8, 2000
Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection
B P Hermans, C J Sweeney, R S Foster, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 16, 2001
Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells
M T Yip-Schneider, C J Sweeney, S H Jung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2010
Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer
J Flanagan, P Kathryn Gray, N Hahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 19, 2000
Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer
C J Sweeney, B P Hermans, D K Heilman, et al.
Cancer Research
|
April 20, 2001
The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors
C J Sweeney, K D Miller, S E Sissons, et al.
Page
of 5